HIGH-GRADE ASTROCYTOMA NOT OTHERWISE SPECIFIED (NOS)

Clinical trials for HIGH-GRADE ASTROCYTOMA NOT OTHERWISE SPECIFIED (NOS) explained in plain language.

Never miss a new study

Get alerted when new HIGH-GRADE ASTROCYTOMA NOT OTHERWISE SPECIFIED (NOS) trials appear

Sign up with your email to follow new studies for HIGH-GRADE ASTROCYTOMA NOT OTHERWISE SPECIFIED (NOS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with aggressive brain cancer: early trial tests novel immune therapy

Disease control Ongoing

This early-stage study is testing a new antibody drug called APX005M in children and young adults with brain tumors that have come back or are not responding to treatment, or with a newly diagnosed aggressive brain stem glioma. The main goal is to find the safest dose and underst…

Matched conditions: HIGH-GRADE ASTROCYTOMA NOT OTHERWISE SPECIFIED (NOS)

Phase: PHASE1 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

HIGH-GRADE ASTROCYTOMA NOT OTHERWISE SPECIFIED (NOS)

Get alerted when new HIGH-GRADE ASTROCYTOMA NOT OTHERWISE SPECIFIED (NOS) trials appear

New hope for kids with aggressive brain cancer: early trial tests novel immune therapy